Extended Care in High-Risk Surgical Patient (EXCARE) Pathway in High-risk Surgical Population (EXCARE)
Primary Purpose
Postoperative Complications, Patient Care Team
Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Postoperative Monitoring
High-sensitivity cardiac troponin testing
Sponsored by
About this trial
This is an interventional supportive care trial for Postoperative Complications focused on measuring failure to rescue, high-risk surgical patient
Eligibility Criteria
Inclusion Criteria:
- Age over 16 years;
- Classified as high-risk by the SAMPE Risk Model (30-day mortality >5%);
- Underwent non-cardiac surgeries at the main operating room unit;
- Referred postoperatively to the postanesthesia care unit or intensive care unit.
Exclusion Criteria:
- Patients undergoing procedures performed outside the operating room unit (outpatient, diagnostic, performed under local anesthesia);
- Patients undergoing cardiac surgery with cardiopulmonary bypass and / or referred to the cardiac ICU postoperatively;
- Patients undergoing organ transplantation;
- Low-risk patients (classified as <5% probability of death within 30 days by the SAMPE Risk Model).
Sites / Locations
- Hospital de Clinicas de Porto AlegreRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
EXCARE Pathway Group
Arm Description
The proposed pathway comprises a range of actions that include individual patient-centered risk assessment by the SAMPE Risk Model (30-day probability of death), specialized care in Post-Anesthetic and Intensive Care Units, and also in the surgical wards performed by the nursing, anesthesia, clinic and surgery teams.
Outcomes
Primary Outcome Measures
Mortality
In-hospital mortality within 30 days
Postoperative complications
Postoperative complications within 7-days defined by Post-operative Morbidity Survey (POMS) domains
Secondary Outcome Measures
Length of stay (LOS)
Hospital length of stay (days)
Unplanned intensive care unit (ICU) admission
Admission to ICU due to clinical deterioration within 30 days
Calls to rapid response team (RRT)
Number of calls to the RRT within 30 days
Surgical reintervention
Number of surgical reinterventions within 30 days
Hospital readmission
Hospital readmission within 30 days
Failure to rescue
Death after a treatable complication within 30 days
High-sensitivity cardiac troponin levels
High-sensitivity cardiac troponin (hs-cTn) elevation due to myocardial injury (defined as any hs-cTn concentration greater than the 99th-percentile upper reference limit.) 3 categories:
Acute myocardial injury due to myocardial infarction (requires at least 1 of the following: symptoms of myocardial ischemia, new ischemic electrocardiographic changes, new ischemic regional wall-motion abnormalities on cardiac imaging, and/or an acute coronary thrombus on coronary angiography) or nonischemic causes (documented nonischemic etiology);
Myocardial Injury After Noncardiac Surgery (MINS): myocardial injury caused by ischemia (that may or may not result in necrosis), has prognostic relevance and occurs during or within 30 days after noncardiac surgery.
Chronic myocardial injury: stable but elevated troponin.
Full Information
NCT ID
NCT04187664
First Posted
December 3, 2019
Last Updated
June 25, 2020
Sponsor
Hospital de Clinicas de Porto Alegre
1. Study Identification
Unique Protocol Identification Number
NCT04187664
Brief Title
Extended Care in High-Risk Surgical Patient (EXCARE) Pathway in High-risk Surgical Population
Acronym
EXCARE
Official Title
Implementation of the Extended Care in High-Risk Surgical Patient (EXCARE) Pathway in High-risk Non-cardiac Surgical Population: Impact on Morbidity and 30-day Mortality
Study Type
Interventional
2. Study Status
Record Verification Date
June 2020
Overall Recruitment Status
Unknown status
Study Start Date
January 30, 2019 (Actual)
Primary Completion Date
July 31, 2021 (Anticipated)
Study Completion Date
July 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital de Clinicas de Porto Alegre
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
High risk surgical patients are subject to complications that impact rehabilitation time, overall mortality and costs. This project proposes the creation of a post-surgery care pathway called Extended Care in High-Risk Surgical Patients (EXCARE) in the form of coordinated multiprofessional actions dedicated to high-risk non-cardiac surgical patients with the aim of improving the postoperative outcomes. The proposed pathway comprises a range of actions that include individual patient-centered risk assessment by the Anaesthesia and Perioperative Medicine Service (SAMPE) Risk Model (30-day probability of death), specialized care in Post-Anesthetic and Intensive Care Units (ICU), and also in the surgical wards performed by the nursing, anesthesia, clinic and surgery teams.
This is a quasi-experiment in which the clinical effectiveness of the extended care will be analyzed using a before-and-after comparison, the primary outcome being 30-day surgical mortality and postoperative complications at day 7 defined by PostOperative Morbidity Survey (POMS), a reliable and valid survey of short-term postoperative morbidity in major elective surgery. POMS domains evaluated are: pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, haematological and wound complications.
Secondary outcomes include 30-day mortality, hospital length of stay, number of Rapid Response Team calls, unplanned postoperative ICU admission, surgical reintervention, failure to rescue and hospital readmission. High-sensitive cardiac troponin (hs-cTn) levels will be measured before surgery and daily until 48 hours postoperatively to identify patients with myocardial injury (defined as any hs-cTn concentration greater than the 99th-percentile upper reference limit).
Detailed Description
Study Strengths and Limitations: This is the first study to evaluate the implementation of surgical patient stratification using the SAMPE Risk Model, pioneering the creation of a multidisciplinary care pathway that involves nursing and medical teams, and can be consolidated as a future standard of assistance. The care bundle, using an objective risk communication tool, is expected to integrate the teams involved in the perioperative care, reducing the fragmentation of care and, consequently, postoperative complications. The study is designed to use historical controls (before and after) and is therefore inherently vulnerable to the biases of this design. It will be conducted in a single teaching hospital and referral centre that provides care to patients from across southern Brazil through the national unified health system centre, which can therefore limit its external validity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Complications, Patient Care Team
Keywords
failure to rescue, high-risk surgical patient
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Quasi-experimental study, nonrandomized, pre-post intervention study
Masking
None (Open Label)
Allocation
N/A
Enrollment
1720 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
EXCARE Pathway Group
Arm Type
Experimental
Arm Description
The proposed pathway comprises a range of actions that include individual patient-centered risk assessment by the SAMPE Risk Model (30-day probability of death), specialized care in Post-Anesthetic and Intensive Care Units, and also in the surgical wards performed by the nursing, anesthesia, clinic and surgery teams.
Intervention Type
Behavioral
Intervention Name(s)
Postoperative Monitoring
Intervention Description
Nursing and medical staff will monitor patients vital signs and clinical deterioration triggers twice as often as in previous ward care.
Intervention Type
Diagnostic Test
Intervention Name(s)
High-sensitivity cardiac troponin testing
Intervention Description
High-risk patients will have their high-sensitivity cardiac troponin tested preoperatively and daily for the first 48h postoperatively
Primary Outcome Measure Information:
Title
Mortality
Description
In-hospital mortality within 30 days
Time Frame
30 days
Title
Postoperative complications
Description
Postoperative complications within 7-days defined by Post-operative Morbidity Survey (POMS) domains
Time Frame
7 days
Secondary Outcome Measure Information:
Title
Length of stay (LOS)
Description
Hospital length of stay (days)
Time Frame
6 months
Title
Unplanned intensive care unit (ICU) admission
Description
Admission to ICU due to clinical deterioration within 30 days
Time Frame
30 days
Title
Calls to rapid response team (RRT)
Description
Number of calls to the RRT within 30 days
Time Frame
30 days
Title
Surgical reintervention
Description
Number of surgical reinterventions within 30 days
Time Frame
30 days
Title
Hospital readmission
Description
Hospital readmission within 30 days
Time Frame
30 days
Title
Failure to rescue
Description
Death after a treatable complication within 30 days
Time Frame
30 days
Title
High-sensitivity cardiac troponin levels
Description
High-sensitivity cardiac troponin (hs-cTn) elevation due to myocardial injury (defined as any hs-cTn concentration greater than the 99th-percentile upper reference limit.) 3 categories:
Acute myocardial injury due to myocardial infarction (requires at least 1 of the following: symptoms of myocardial ischemia, new ischemic electrocardiographic changes, new ischemic regional wall-motion abnormalities on cardiac imaging, and/or an acute coronary thrombus on coronary angiography) or nonischemic causes (documented nonischemic etiology);
Myocardial Injury After Noncardiac Surgery (MINS): myocardial injury caused by ischemia (that may or may not result in necrosis), has prognostic relevance and occurs during or within 30 days after noncardiac surgery.
Chronic myocardial injury: stable but elevated troponin.
Time Frame
3 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age over 16 years;
Classified as high-risk by the SAMPE Risk Model (30-day mortality >5%);
Underwent non-cardiac surgeries at the main operating room unit;
Referred postoperatively to the postanesthesia care unit or intensive care unit.
Exclusion Criteria:
Patients undergoing procedures performed outside the operating room unit (outpatient, diagnostic, performed under local anesthesia);
Patients undergoing cardiac surgery with cardiopulmonary bypass and / or referred to the cardiac ICU postoperatively;
Patients undergoing organ transplantation;
Low-risk patients (classified as <5% probability of death within 30 days by the SAMPE Risk Model).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Luciana Cadore Stefani, PhD
Phone
+555133598226
Email
lpstefani@hcpa.edu.br
First Name & Middle Initial & Last Name or Official Title & Degree
Adriene Stahlschmidt, MD
Phone
+555133598226
Email
adristah@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luciana Cadore Stefani, PhD
Organizational Affiliation
Hospital de Clinicas de Porto Alegre
Official's Role
Study Director
Facility Information:
Facility Name
Hospital de Clinicas de Porto Alegre
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90035007
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luciana Cadore Stefani, PhD
Phone
+555133598226
Email
lpstefani@hcpa.edu.br
First Name & Middle Initial & Last Name & Degree
Luciana Cadore Stefani, PhD
First Name & Middle Initial & Last Name & Degree
Adriene Stahlschmidt, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29084236
Citation
Stefani LC, Gutierrez CS, Castro SMJ, Zimmer RL, Diehl FP, Meyer LE, Caumo W. Derivation and validation of a preoperative risk model for postoperative mortality (SAMPE model): An approach to care stratification. PLoS One. 2017 Oct 30;12(10):e0187122. doi: 10.1371/journal.pone.0187122. eCollection 2017.
Results Reference
background
PubMed Identifier
28444280
Citation
Writing Committee for the VISION Study Investigators; Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, Walsh M, Abraham V, Pearse R, Wang CY, Sessler DI, Kurz A, Szczeklik W, Berwanger O, Villar JC, Malaga G, Garg AX, Chow CK, Ackland G, Patel A, Borges FK, Belley-Cote EP, Duceppe E, Spence J, Tandon V, Williams C, Sapsford RJ, Polanczyk CA, Tiboni M, Alonso-Coello P, Faruqui A, Heels-Ansdell D, Lamy A, Whitlock R, LeManach Y, Roshanov PS, McGillion M, Kavsak P, McQueen MJ, Thabane L, Rodseth RN, Buse GAL, Bhandari M, Garutti I, Jacka MJ, Schunemann HJ, Cortes OL, Coriat P, Dvirnik N, Botto F, Pettit S, Jaffe AS, Guyatt GH. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA. 2017 Apr 25;317(16):1642-1651. doi: 10.1001/jama.2017.4360.
Results Reference
background
PubMed Identifier
22998715
Citation
Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012 Sep 22;380(9847):1059-65. doi: 10.1016/S0140-6736(12)61148-9.
Results Reference
background
PubMed Identifier
25188264
Citation
Ferraris VA, Bolanos M, Martin JT, Mahan A, Saha SP. Identification of patients with postoperative complications who are at risk for failure to rescue. JAMA Surg. 2014 Nov;149(11):1103-8. doi: 10.1001/jamasurg.2014.1338.
Results Reference
background
PubMed Identifier
10439777
Citation
Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, Phillips-Bute BG, Newman MF, Mythen MG. The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg. 1999 Aug;89(2):514-9. doi: 10.1097/00000539-199908000-00050.
Results Reference
background
PubMed Identifier
35167136
Citation
Stahlschmidt A, Passos SC, Cardoso GR, Schuh GJ, Gutierrez CS, Castro SMJ, Caumo W, Pearse RM; Ex-Care collaborative; Stefani LC. Enhanced peri-operative care to improve outcomes for high-risk surgical patients in Brazil: a single-centre before-and-after cohort study. Anaesthesia. 2022 Apr;77(4):416-427. doi: 10.1111/anae.15671. Epub 2022 Feb 15.
Results Reference
derived
Learn more about this trial
Extended Care in High-Risk Surgical Patient (EXCARE) Pathway in High-risk Surgical Population
We'll reach out to this number within 24 hrs